Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


CropLogic Recognised At Annual TIN100 Awards

Media release

CropLogic Recognised At Annual TIN100 Awards

Christchurch, 20 October 2016 - Precision agriculture firm, CropLogic, has been named one of the most promising early stage companies at the annual TIN100 Awards announced in Auckland last night.

The TIN100 Awards recognise the leading technology exporters in New Zealand following the release of the annual TIN100 Report. The Report analyses the performance of the country’s largest exporters in the areas of ICT, High-tech Manufacturing and Biotechnology.

CropLogic was amongst ten shortlisted companies including 8i, BioLumic, Engender Technologies, Footfalls & Heartbeats, Hydroxsys, Invert Robotics, Mars Bio-imaging Ltd, Parrot Analytics and Timely.

Jamie Cairns, CropLogic’s CEO, said: “We’re proud to be recognised at the 2016 TIN100 Awards alongside so many innovative New Zealand companies.

“The Award comes at a time when New Zealand’s technology export sector is really starting to establish itself on an international stage. We’re delighted to be part of that, and to be contributing to the country’s economic success.

“Our aim at CropLogic is to become the leading provider of end-to-end agronomy services to global crop-growers. We developed the technology here in New Zealand and have been able to create a proven decision support system to achieve more sustainable farming practices by improving yields, significantly increasing efficiencies and boosting profits.”


About CropLogic

CropLogic is developing a world-class decision support system for growers, with a particular emphasis on forecasting irrigation and fertiliser requirements and accurate prediction of harvest yield for most crops.

Founded in 2010 with patented plant models developed by New Zealand Institute of Plant & Food Research at its core, CropLogic has built upon its intellectual property position by integrating sensors and Internet of Things technologies into a comprehensive and predictive decision support system.

About Jamie Cairns, CEO

Jamie was previously CEO of “Snap”, a multi award-winning nationwide telecommunications business, where he was also instrumental in spinning-out the ICT infrastructure company “The Colocation Company”. Jamie has extensive experience in the ICT and telecommunications sectors, having been employed by some of the largest companies in both NZ and the UK, and also has a successful background in both central and local Government roles. Jamie holds an MBA and BSc (Computer Science) and traces his career back to the rural sector in which he was raised.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Marine And Freshwater Reports: EDS Calls For Urgent Action On Marine Management

“There are some big issues to address. These include many marine species and habitats that are in serious trouble. Of the sample investigated, the report finds that 22% of marine mammals, 90% of seabirds and 80% of shorebirds are threatened with or actually at risk of extinction..." More>>


$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>


New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>


Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>